On Apr. 23, 2020, CareDx and Johns Hopkins University announced the launch of the ALARM (AlloSure Lung Allograft Remote Monitoring) Partnership. With the COVID 19 pandemic, there has been an emergent need to implement patient home isolation to reduce the risk of community spread and exposure to the dangerous virus. For high-risk populations who need close medical monitoring, Johns Hopkins has adopted CareDxﾒs RemoTraC for their kidney, heart, and lung transplant patients.